Sleep Apnea Devices Market – By Product, By End Use, Global Forecast, 2025 to 2034

Sleep Apnea Devices Market Size

The global sleep apnea devices market size was valued at USD 7.2 billion in 2024 and is expected to exhibit growth at a CAGR of 7.8% from 2025 to 2034. High market growth can be attributed to the increasing incidence of sleep apnea and related comorbidities, surging awareness of sleep apnea and sleep disorders, and the rising aging population amplifying demand, among other contributing factors.
 

Sleep apnea is a prevalent condition affecting millions of individuals globally, with many cases remaining undiagnosed. According to the National Institutes of Health, nearly 1 billion people worldwide suffer from sleep apnea, including 936 million cases of obstructive sleep apnea. The rising prevalence of sleep apnea can be attributed to factors such as an aging population, increasing obesity rates, and lifestyle changes.
 

As awareness grows about the serious health risks of untreated sleep apnea—including cardiovascular diseases, diabetes, and stroke—more individuals are seeking medical intervention. This surge in awareness and diagnosis has significantly increased the demand for sleep apnea devices, driving growth in this market.
 

Additionally, the increasing awareness of sleep apnea symptoms such as loud snoring, daytime fatigue, and difficulty concentrating has encouraged more people to seek medical evaluation. Enhanced diagnostic techniques, such as home sleep tests and in-lab polysomnography, have made it easier to identify cases of sleep apnea. As more people are diagnosed with the condition, the demand for sleep apnea devices, including CPAP (continuous positive airway pressure) machines, BiPAP, and other therapeutic devices, continues to grow.
 

Sleep apnea devices are medical apparatuses designed to manage and treat sleep apnea by ensuring unobstructed breathing during sleep. These devices play a crucial role in mitigating the health risks associated with untreated sleep apnea, thereby enhancing patient outcomes and quality of life.
 

Sleep Apnea Devices Market Trends

As more patients seek convenient, efficient, and user-friendly devices that can deliver reliable therapy without compromising on quality, the market is experiencing a shift toward compact, portable, and advanced solutions that cater to the needs of both home and on-the-go users.
 

• With a growing preference for home-based healthcare and management of chronic conditions, patients are increasingly turning to portable sleep apnea devices that offer both comfort and effectiveness. Portable CPAP machines, BiPAP devices, and other sleep apnea solutions are becoming popular as they allow users to manage their condition without the need for frequent hospital visits. The convenience of home therapy is driving the demand for portable devices, particularly among those with mild to moderate sleep apnea who may not require in-hospital monitoring.
   
• Additionally, many patients with sleep apnea, especially those who require continuous positive airway pressure (CPAP) therapy, find it challenging to maintain treatment during travel or while maintaining an active lifestyle. Portable, high-performance devices are designed to be lightweight, compact, and easy to use, making them ideal for individuals who travel frequently or lead busy lifestyles. These devices allow patients to continue their therapy without the burden of heavy, cumbersome equipment, further driving market growth.
   
• Technological advancements have revolutionized the design of sleep apnea devices, leading to the development of portable CPAP and BiPAP machines that deliver uncompromised performance. These modern devices provide the same high-level efficacy as their traditional, larger counterparts but in a compact and travel-friendly format. Equipped with features such as battery operation, quieter functionality, and enhanced comfort settings, these portable devices ensure a superior therapy experience.
   

Sleep Apnea Devices Market Analysis

Based on product, the market is classified into therapeutics and diagnostics. The therapeutics segment generated the highest revenue of USD 4.6 billion in 2024.
 

• CPAP and BiPAP machines, the primary therapeutic devices for obstructive sleep apnea (OSA), continue to dominate the market due to their proven efficacy in maintaining open airways during sleep.
   
• CPAP machines deliver a continuous flow of air through a mask, keeping the airway open, while BiPAP machines offer variable air pressure for inhalation and exhalation, providing a more comfortable solution for patients with complex sleep apnea. These devices are widely used across mild to severe cases of sleep apnea, contributing significantly to the market share of the therapeutics segment.
   
• Moreover, patient compliance is a critical factor in the success of sleep apnea therapy, and therapeutic devices have evolved to improve comfort, ease of use, and overall patient satisfaction. Innovations such as quieter machines, smaller, more comfortable masks, and advanced humidity settings have significantly improved user experience, driving higher adoption rates. As patient compliance with CPAP and BiPAP therapy improves, the therapeutics segment benefits from greater sales and market share, as more individuals with sleep apnea seek long-term, effective treatments.
   

Based on end use, the sleep apnea devices market is segmented into home care settings and individuals and sleep laboratories and hospitals. The home care settings and individuals segment dominated the market in 2024 and is anticipated to reach USD 8.9 billion by the 2034.
 

• Home care is often a more cost-effective option compared to long-term treatment in healthcare facilities. This is particularly important in the region, where healthcare costs can be a barrier to accessing continuous treatment. By managing sleep apnea at home, patients can reduce expenses related to hospital stays and frequent doctor visits.
   
• Additionally, the availability of affordable sleep apnea devices and the expansion of insurance coverage for home-based treatments are making these options more accessible to a broader population.
   
• Furthermore, the expansion of telemedicine in the region is significantly boosting the demand for sleep apnea devices in home care settings. Through telemedicine, healthcare providers can remotely monitor patient treatment progress and make timely adjustments to their therapy, enhancing the effectiveness of sleep apnea management.
   
• The integration of remote monitoring technologies with devices like CPAP machines is particularly advantageous for home care, as it ensures continuous, personalized care without requiring frequent in-person visits. This approach is gaining traction among patients and healthcare providers, further accelerating the adoption of home-based sleep apnea therapies.
   

The U.S. sleep apnea devices market accounted for USD 2.5 billion in market revenue in 2024 and is anticipated to grow at a CAGR of 7.4% between 2025 to 2034 period.
 

• The private healthcare sector in the region is expanding, with more people opting for private health insurance and services. This growth is contributing to increased access to diagnostic and therapeutic solutions for sleep apnea.
   
• Private healthcare providers often have more resources and can offer advanced sleep apnea treatments, including the latest devices.
   
• The expansion of this sector is driving demand for sleep apnea devices, particularly among individuals who prefer quicker access to healthcare services.
   

France sleep apnea devices market is projected to grow remarkably in the coming years.
 

• In France, there is increasing awareness about the health implications of sleep disorder, particularly sleep apnea. Educational campaigns and media coverage have contributed to a better understanding of the condition, prompting more individuals to seek medical attention and treatment.
   
• Additionally, France efforts to improve access to healthcare services, especially in urban and semi-urban areas, have made it easier for patients to obtain diagnosis and treatment for sleep apnea. The expansion of healthcare facilities, including specialized sleep centers, has played a crucial role in meeting the growing demand for sleep apnea devices.
   

Japan holds a dominant position in the Asia Pacific sleep apnea devices market.
 

• Japan healthcare infrastructure is continually improving, particularly in urban areas where there is better access to specialized care. The availability of sleep centers and medical facilities equipped to diagnose and treat sleep apnea has facilitated the increased use of sleep apnea devices in the country.
   
• Additionally, the Japanese government has been proactive in improving healthcare access and quality, which includes initiatives to enhance the diagnosis and treatment of chronic conditions such as sleep apnea. These efforts have helped increase the adoption of medical devices designed to manage sleep disorders.
   

Sleep Apnea Devices Market Share

Several key players in the market are making strides in product innovation and strategic partnerships to maintain market leadership. Companies are investing heavily in R&D to develop advanced sleep tech devices with enhanced features such as AI integration, portable design, and user-friendly format. Additionally, partnerships with healthcare providers are being forged to improve product accessibility in emerging markets. Regulatory compliance and adherence to international quality standards are crucial aspects of the strategies employed by these companies to cater to a global market. These developments are helping companies meet the increasing demand for safe and efficient sleep apnea devices.
 

Sleep Apnea Devices Market Companies

Prominent players operating in the sleep apnea devices industry include:

• Asahi KASEI
• BMC
• Cadwell
• Drive DeVilbiss
• FISHER & PAYKEL
• Itamar Medical
• Philips
• LivaNova
• natus
• NIHON KOHDEN
• ResMed
• Teleflex
• WEINMANN
   

Sleep Apnea Devices Industry News:

• In June 2021, Cadwell announced a partnership with EnsoData, a healthcare artificial intelligence (AI) company dedicated to improving the lives of medical professionals and their patients. Cadwell integrated EnsoData EnsoSleep AI scoring solution by modifying its Easy III PSG software platform. This deeper integration enabled clinicians to spend less time on manual data analysis and focus more time on enhancing the patient care experience and improving treatment outcomes.
   

The sleep apnea devices market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Therapeutics
  • Airway clearance systems  
  • Positive airway pressure (PAP) devices    
    • Continuous positive airway pressure (CPAP) devices
    • Bilevel positive airway pressure (BiPAP) devices
    • Automatic positive airway pressure (APAP) devices
  • Adaptive servo-ventilation (ASV) devices
  • Oral appliances        
    • Mandibular advancement devices
    • Tongue-retaining devices
    • Rapid maxillary expansion
    • Mouth guards
  • Other therapeutics
• Diagnostics
  • Polysomnography (PSG) device
    • Ambulatory PSG devices
    • Clinical PSG devices
  • Actigraphy systems
  • Pulse oximeters
  • Home sleep testing (HST) devices
    • Type 2
    • Type 3
    • Type 4
  • Respiratory polygraph

Market, By End Use

• Home care settings and individuals
• Sleep laboratories and hospitals

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE